image dons

I make a donation

ALPHEUS

Evaluating the effect of a loading dose of Ticagrelor compared to Clopidogrel to decrease ischemic events in patients undergoing a scheduled coronary angioplasty.

Terminée

Colloquium "Rythme et conduction" (23 avril 2024)
Inscrivez-vous !

La Grande Journée du Coeur (13 juin 2023)
Attention : plus que quelques places restantes !

La Grande Journée du Coeur (mardi 13 juin 2023)
Les présentations sont en ligne

logo étude

objectif

Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS) : a randomised, open-label, phase 3b trial

date de réalisation

2017

nombre de patients

1900

nombre de centres participants

International multicentric trial

type de financement

Private (AstraZeneca)

Référence

NCT02617290

A study conducted by Fonds de Dotation ACTION.
Find out details and results on the dedicated page

ALPHEUS conducted by Fonds de Dotation ACTION

Autres études

+

AMUNDSEN

En cours


A phase IV, multicentric, randomized, real-world pragmatic study that compares a strategy of early LDL reduction with anti-PCSK9 in patients defined as extreme high risk by 2019 ESC/EAS guidelines vs....
+

EDUC-DAI

En cours


Impact of therapeutic education on the quality of life and the anxiety of patients with a defibrillator.
+

AFLOAT

En cours


To assess if flecainide is more efficient than standard of care (control group) to prevent AF occurrence during the 3 months after PFO closure.